Predictive Factors of Deep Remission Achievement in Patients With Crohn's Disease Treated With Anti-TNF Alfa

被引:0
|
作者
Sebkova, Ladislava
Rodino, Stefano
D'Amico, Teresa
Sacca, Natale
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S228 / S228
页数:1
相关论文
共 50 条
  • [1] PREDICTIVE FACTORS FOR LOSS OF RESPONSE TO ANTI-TNF IN CROHN'S DISEASE
    Moreira dos Santos, Byanca Rossetti
    Marques dos Santos, Carlos Henrique
    Moreira dos Santos, Vitoria Rossetti
    Garcia Torrez, Claudia Yanina
    Palomares-Junior, Daniel
    ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2020, 33 (02):
  • [2] Histological inflammation in Crohn's disease in deep remission during treatment with anti-TNFα
    Tursi, Antonio
    Elisei, Walter
    Picchio, Marcello
    Brandimarte, Giovanni
    DIGESTIVE AND LIVER DISEASE, 2014, 46 (06) : 575 - 576
  • [3] Maintenance of deep remission in Crohn's disease after switching from anti-TNF to ustekinumab
    Mantzaris, C.
    Vraka, M.
    Beka, H.
    Georgiadi, T.
    Albani, F.
    Veretanos, C.
    Mountaki, K.
    Trikola, A.
    Archavlis, E.
    Christidou, A.
    Manolakis, A.
    Viazis, N.
    Karampekos, G.
    Philippidis, G.
    Hatzievangelinou, C.
    Tsatsa, A.
    Georgiadou, A.
    Panagopoulou, S.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S366 - S367
  • [4] Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agent
    del Carmen R-Grau, Maria
    Chaparro, Maria
    Mesonero, Francisco
    Barreiro-de Acosta, Manuel
    Castro, Luisa
    Castro, Manuel
    Domenech, Eugeni
    Mancenido, Noemi
    Lazaro Perez-Calle, Jose
    Taxonera, Carlos
    Barrio, Jesus
    De Francisco, Ruth
    Fernandez-Salgado, Estela
    Luzon, Lara
    Merino, Olga
    Oltra, Lorena
    Saro, Cristina
    Bermejo, Fernando
    Garcia-Sanchez, Valle
    Ginard, Daniel
    Gutierrez, Ana
    Vera, Isabel
    Anton, Rosario
    Ber, Yolanda
    Calvet, Xavier
    Gisbert, Javier P.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (06) : 613 - 619
  • [5] TRANSMURAL HEALING IN PATIENTS WITH CROHN'S DISEASE TREATED WITH ANTI-TNF THERAPY
    Pastaud, Clement
    Hordonneau, Constance
    Lambert, Celine
    Vignette, Jeanne
    Pereira, Bruno
    Buisson, Anthony
    GASTROENTEROLOGY, 2020, 158 (06) : S953 - S954
  • [6] Deep Remission in Crohn's Disease Does Not Prevent Disease Relapse After Withdrawal of Anti-TNFα Therapy
    Duricova, Dana
    Bortlik, Martin
    Machkova, Nadezda
    Hruba, Veronika
    Lukas, Martin
    Mitrova, Katarina
    Romanko, Igor
    Bina, Vladislav
    Lukas, Milan
    GASTROENTEROLOGY, 2015, 148 (04) : S61 - S61
  • [7] Fourteen-Year Anti-TNF Therapy in Crohn's Disease Patients: Clinical Characteristics and Predictive Factors
    Osamura, Aisaku
    Suzuki, Yasuo
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (01) : 204 - 208
  • [8] Fourteen-Year Anti-TNF Therapy in Crohn’s Disease Patients: Clinical Characteristics and Predictive Factors
    Aisaku Osamura
    Yasuo Suzuki
    Digestive Diseases and Sciences, 2018, 63 : 204 - 208
  • [9] Stopping anti-TNFα monotherapy in Crohn's disease patients in deep remission and favourable disease characteristics is associated with a high rate of relapse
    Soufleris, K.
    Kafalis, N.
    Fasoulas, K.
    Lazaraki, G.
    Pilpilidis, I.
    Tzilves, D.
    Giouleme, O.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S391 - S391
  • [10] RADIOLOGIC PREDICTORS OF SHORT-TERM CLINICAL REMISSION IN PATIENTS WITH PERIANAL CROHN'S DISEASE TREATED WITH ANTI-TNF THERAPY
    Parlow, Simon
    Macdonald, Blair
    Abdul-Kareem, Ihssan
    Rhee, Gaeun
    Sabri, Elham
    McCurdy, Jeffrey D.
    GASTROENTEROLOGY, 2018, 154 (06) : S186 - S187